You are here

  • Home
  • Archive
  • Volume 13, Issue 1
  • Internet-based asthma self-management program for adults improves asthma control and lung function, but does not reduce exacerbations

Article Text

Article menu
Download PDFPDF
Therapeutics
Randomised controlled trial
Internet-based asthma self-management program for adults improves asthma control and lung function, but does not reduce exacerbations
  1. Mark L Levy
  1. Part-time GP in Harrow, London, UK; Centre for Population Health Sciences, GP Section, University of Edinburgh, Edinburgh, UK
  1. Correspondence to Mark L Levy
    Kenton Bridge Medical Centre, 155–175 Kenton Road, Kenton HA3 0YX, UK; marklevy{at}animalswild.com

https://doi.org/10.1136/ebn1029

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Commentary on: van der Meer V, Bakker MJ, van den Hout WB, et al. SMASHING (Self-Management in Asthma Supported by Hospitals, ICT, Nurses and General Practitioners) Study Group. Internet-based self-management plus education compared with usual care in asthma: a randomized trial. Ann Intern Med 2009;151:110–20.

    Many patients with asthma are reluctant to attend their doctor’s office for routine review appointments. As a result, patients miss the opportunity to have their asthma assessed and their inhaler technique checked; they also forgo introduction to and reinforcement of personalised self-management plans (SMPs). Telephone consultations address some of these issues.1 The article by van der Meer and colleagues offers another type of solution to the problem of non-attendance for face-to-face consultations. Their randomised controlled trial compared Internet-based self-management plus education with usual care in asthma.

    During a run-in period, the researchers …

    View Full Text

    Footnotes

    • Competing interests ML has accepted sponsorship to attend conferences, fees for lecturing, and fees for participation on advisory boards for the following companies: GlaxoSmithKline, Boehringer Ingelheim, MEDA Pharmaceuticals, Chiesi, AstraZeneca, Pfizer and Nycomed.